NYESO1, which is also wellknown as New York esophageal squamous cell carcinoma 1, is an efficient target for cancer immunotherapy. This antigen is a member of cancertestis antigens (CTAs) and is highly expressed in various cancers, including melanoma, ov
Tag:
Native
Quelle:
Human
Expression System:
HEK293
Formulierung:
Liquid
Target-Kategorie:
NY-ESO-1
Anwendungsbeschreibung:
Binding assay by FACS and cell based ELISA.
CHEK-STP114-2Vials
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten